UBS Upgrades Jazz Pharmaceuticals to Buy, Sets $307 Target
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Understanding when most people start planning for retirement can help you avoid delays. Find out the trends and best practices for timely planning.
22,030 articlesUBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
SUI has introduced gasless stablecoin transfers, eliminating on-chain fees for supported assets and expanding enterpr...
Palo Alto Networks is outperforming Palantir this year, driven by AI-native security demand and margin gains, while i...
When markets wobble, fear can block smart moves. This guide walks you through a calm, practical approach to a market ...
As Costco prepares to report Q4 results, investors weigh whether costco wholesale corp's stock deserves a spot in the...
Vanguard’s FTSE Developed Markets ETF has posted stronger gains than the S&P 500 in 2026, drawing renewed investor in...
AI stocks keep surprising investors with durable growth. Here’s a detailed, practical case for a single stock that ch...
A highly focused 3x Korea fund rides a memory-chip demand wave to striking gains, but risk factors and regulatory scr...
Meta's AI forecast points to a near-term Bitcoin dip followed by a multi-week rally as ETF flows and policy catalysts...
The ripple (xrp) price down narrative dominates crypto desks as XRP slides toward $1 amid a market-wide pullback. Her...
Regulators in the UK are turning up the heat on crypto perpetual contracts. The latest wave centers on Hyperliquid an...
KORU, a triple-leveraged bet on South Korea stocks, sank 42% in a single trading day as chipmakers slid and risk appe...